Correlation Between Eterna Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on Eterna Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for Eterna Therapeutics and ProMIS Neurosciences
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eterna and ProMIS is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Eterna Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days Eterna Therapeutics is expected to generate 2.48 times more return on investment than ProMIS Neurosciences. However, Eterna Therapeutics is 2.48 times more volatile than ProMIS Neurosciences. It trades about 0.03 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.07 per unit of risk. If you would invest 25.00 in Eterna Therapeutics on December 27, 2024 and sell it today you would lose (2.47) from holding Eterna Therapeutics or give up 9.88% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Eterna Therapeutics vs. ProMIS Neurosciences
Performance |
Timeline |
Eterna Therapeutics |
ProMIS Neurosciences |
Eterna Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eterna Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite Eterna Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.Eterna Therapeutics vs. Arcus Biosciences | Eterna Therapeutics vs. Cullinan Oncology LLC | Eterna Therapeutics vs. Annexon | Eterna Therapeutics vs. Structure Therapeutics American |
ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |